Trials / Completed
CompletedNCT07111468
Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis
A Multicenter, Randomized, Double-blind, Parallel, Active-controlled, Superiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 286 (actual)
- Sponsor
- Yuhan Corporation · Industry
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A Multicenter, Randomized, Double-blind, Parallel, Active-controlled, Superiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of YHP2401 Compared to YHR2402 and YHR2403 for Acute Bronchitis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YHP2401 | Total 7 days of treatment and The daily dose is tid.(YHP2401 + Placebo of YHR2402 + Placebo of YHR2403) |
| DRUG | YHR2402 | Total 7 days of treatment and The daily dose is tid.(Placebo of YHP2401 + YHR2402 + Placebo of YHR2403) |
| DRUG | YHR2403 | Total 7 days of treatment and The daily dose is tid.(Placebo of YHP2401 + Placebo of YHR2402 + YHR2403) |
Timeline
- Start date
- 2025-08-19
- Primary completion
- 2026-01-15
- Completion
- 2026-01-26
- First posted
- 2025-08-08
- Last updated
- 2026-02-09
Locations
11 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07111468. Inclusion in this directory is not an endorsement.